Article
Comparisons of clinical phenotype, radiological and laboratory features, and therapy of neuromyelitis optica spectrum disorder by regions: update and challenges.
Autoimmunity reviews - 1 Jan 2022
Liu Caiyun, Shi Mingchao, Zhu Mingqin, Chu Fengna, Jin Tao, Zhu Jie
Abstract excerpt
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disease of the central nervous system (CNS) associated with autoantibody (ab) to aquaporin-4 (AQP4). There is obvious variation between regions and countries in the epidemiology, clinical features and management in NMOSD. Based on published population-based observation and cohort studies, the different clinical pattern of NMOSD has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
